| Antitumor effect of locally produced CD95 ligand KI Seino, N Kayagaki, KO Okumura, H Yagita Nature medicine 3 (2), 165-170, 1997 | 389 | 1997 |
| Requirement for natural killer T (NKT) cells in the induction of allograft tolerance K Seino, K Fukao, K Muramoto, K Yanagisawa, Y Takada, S Kakuta, ... Proceedings of the National Academy of Sciences 98 (5), 2577-2581, 2001 | 358 | 2001 |
| The NKT cell system: bridging innate and acquired immunity M Taniguchi, K Seino, T Nakayama Nature immunology 4 (12), 1164-1165, 2003 | 326 | 2003 |
| Cutting edge: chemotactic activity of soluble Fas ligand against phagocytes K Seino, K Iwabuchi, N Kayagaki, R Miyata, I Nagaoka, A Matsuzawa, ... The Journal of Immunology 161 (9), 4484-4488, 1998 | 213 | 1998 |
| Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response S Fujita, K Seino, K Sato, Y Sato, K Eizumi, N Yamashita, M Taniguchi, ... Blood 107 (9), 3656-3664, 2006 | 191 | 2006 |
| Down‐regulation of the invariant Vα14 antigen receptor in NKT cells upon activation M Harada, K Seino, H Wakao, S Sakata, Y Ishizuka, T Ito, S Kojo, ... International immunology 16 (2), 241-247, 2004 | 181 | 2004 |
| Generation of cloned mice by direct nuclear transfer from natural killer T cells K Inoue, H Wakao, N Ogonuki, H Miki, K Seino, R Nambu-Wakao, S Noda, ... Current Biology 15 (12), 1114-1118, 2005 | 179 | 2005 |
| Functionally distinct NKT cell subsets and subtypes K Seino, M Taniguchi The Journal of experimental medicine 202 (12), 1623-1626, 2005 | 174 | 2005 |
| Chemotherapy-induced IL34 enhances immunosuppression by tumor-associated macrophages and mediates survival of chemoresistant lung cancer cells M Baghdadi, H Wada, S Nakanishi, H Abe, N Han, WE Putra, D Endo, ... Cancer research 76 (20), 6030-6042, 2016 | 172 | 2016 |
| Contribution of Fas ligand to T cell-mediated hepatic injury in mice K Seino, N Kayagaki, K Takeda, K Fukao, K Okumura, H Yagita Gastroenterology 113 (4), 1315-1322, 1997 | 170 | 1997 |
| Impaired proliferative response of Vα24 NKT cells from cancer patients against α-galactosylceramide K Yanagisawa, K Seino, Y Ishikawa, M Nozue, T Todoroki, K Fukao The Journal of Immunology 168 (12), 6494-6499, 2002 | 155 | 2002 |
| Chemotherapy-derived inflammatory responses accelerate the formation of immunosuppressive myeloid cells in the tissue microenvironment of human pancreatic cancer S Takeuchi, M Baghdadi, T Tsuchikawa, H Wada, T Nakamura, H Abe, ... Cancer research 75 (13), 2629-2640, 2015 | 153 | 2015 |
| Differential role of thymic stromal lymphopoietin in the induction of airway hyperreactivity and Th2 immune response in antigen-induced asthma with respect to natural killer T … Y Nagata, H Kamijuku, M Taniguchi, S Ziegler, K Seino International archives of allergy and immunology 144 (4), 305-314, 2007 | 142 | 2007 |
| IL-21–induced Bε cell apoptosis mediated by natural killer T cells suppresses IgE responses M Harada, K Magara-Koyanagi, H Watarai, Y Nagata, Y Ishii, S Kojo, ... The Journal of experimental medicine 203 (13), 2929-2937, 2006 | 138 | 2006 |
| Natural killer T cell‐mediated antitumor immune responses and their clinical applications K Seino, S Motohashi, T Fujisawa, T Nakayama, M Taniguchi Cancer science 97 (9), 807-812, 2006 | 127 | 2006 |
| Macrophage activation syndrome and COVID-19 R Otsuka, K Seino Inflammation and regeneration 40 (1), 19, 2020 | 125 | 2020 |
| Interleukin-34, a comprehensive review M Baghdadi, Y Umeyama, N Hama, T Kobayashi, N Han, H Wada, ... Journal of leukocyte biology 104 (5), 931-951, 2018 | 121 | 2018 |
| Cutting edge: critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance X Jiang, T Shimaoka, S Kojo, M Harada, H Watarai, H Wakao, N Ohkohchi, ... The Journal of immunology 175 (4), 2051-2055, 2005 | 118 | 2005 |
| Induction of regulatory properties in dendritic cells by Vα14 NKT cells S Kojo, K Seino, M Harada, H Watarai, H Wakao, T Uchida, T Nakayama, ... The Journal of Immunology 175 (6), 3648-3655, 2005 | 117 | 2005 |
| High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancers M Baghdadi, H Endo, A Takano, K Ishikawa, Y Kameda, H Wada, ... Scientific reports 8 (1), 418, 2018 | 114 | 2018 |
